ARBORGEN HOLDINGS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.15 NZD | +3.45% |
|
+3.45% | -11.24% |
| 07-02 | New Zealand Shares Flat on Weakening Business Confidence; Scott Technology Secures NZ$19 Million Contracts in Europe | MT |
| 07-02 | ArborGen Completes Sale of In-Vitro Seedling Business | MT |
Valuation
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 73.13 | 81.76 | 120.3 | 95.47 | 78.54 | 76.01 |
| Enterprise Value (EV) 1 | 134.3 | 119.3 | 137.8 | 117 | 78.54 | 94.88 |
| P/E ratio | -18.1 x | 19.9 x | 52.3 x | -23 x | -238 x | 8.9 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.79 x | 1.13 x | 1.65 x | 1.03 x | 0.71 x | 0.63 x |
| EV / Revenue | 1.45 x | 1.65 x | 1.89 x | 1.26 x | 0.71 x | 0.79 x |
| EV / EBITDA | 8.62 x | 5.4 x | 7.06 x | - | 3.76 x | 3.5 x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 497,464 | 498,509 | 501,213 | 502,498 | 506,706 | 506,706 |
| Reference price 2 | 0.1470 | 0.1640 | 0.2400 | 0.1900 | 0.1550 | 0.1500 |
| Announcement Date | 5/28/20 | 5/27/21 | 5/30/22 | 5/30/23 | 5/30/24 | - |
1NZD in Million2NZD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 92.3 | 72.33 | 72.85 | 92.82 | 110.6 | 120.1 |
| EBITDA 1 | 15.57 | 22.1 | 19.52 | - | 20.91 | 27.13 |
| EBIT 1 | -2.433 | 6.314 | 4.117 | 2.647 | 7.351 | 13.82 |
| Operating Margin | -2.64% | 8.73% | 5.65% | 2.85% | 6.65% | 11.5% |
| Earnings before Tax (EBT) 1 | -6.164 | 3.568 | -4.592 | - | -2.614 | 12.13 |
| Net income 1 | -4.38 | 4.392 | 2.602 | - | -0.3267 | 8.761 |
| Net margin | -4.75% | 6.07% | 3.57% | - | -0.3% | 7.29% |
| EPS 2 | -0.008110 | 0.008240 | 0.004590 | -0.008270 | -0.000650 | 0.0168 |
| Free Cash Flow | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/28/20 | 5/27/21 | 5/30/22 | 5/30/23 | 5/30/24 | - |
1NZD in Million2NZD
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 61.1 | 37.6 | 17.5 | 21.5 | - | 18.9 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.925 x | 1.701 x | 0.8984 x | - | - | 0.6957 x |
| Free Cash Flow | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | 15 | 6.45 | 7.01 | 3.64 | - | 3.59 |
| Capex / Sales | 16.21% | 8.91% | 9.63% | 3.92% | - | 2.99% |
| Announcement Date | 5/28/20 | 5/27/21 | 5/30/22 | 5/30/23 | 5/30/24 | - |
1NZD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- ARB Stock
- Financials ArborGen Holdings Limited
